Work

Supplementary Figure S1 from TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure S1 shows that expression of natural cytotoxicity receptors and GD2 on neuroblastoma cells are not affected by TGFbeta1 or galunisertib.

DOI: 10.1158/1078-0432.22463910.v1

Authors: Hung C. Tran, Zesheng Wan, Michael A. Sheard, Jianping Sun, Jeremy R. Jackson, Jemily Malvar, Yibing Xu, Larry Wang, Richard Sposto, Eugene S. Kim, Shahab Asgharzadeh, Robert C. Seeger

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361968150

Cites:

Cited by:

Related to: 10